comparemela.com

Latest Breaking News On - Lon docs - Page 1 : comparemela.com

Dr Martens plc Declares Dividend of GBX 1 56 (LON:DOCS)

Dr. Martens plc (LON:DOCS – Get Free Report) declared a dividend on Saturday, November 30th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, January 4th will be paid a dividend of GBX 1.56 ($0.02) per share on Friday, February 2nd. This represents a yield of 1.36%. The ex-dividend date of this dividend is Thursday, January 4th. […]

Dr Martens plc (LON:DOCS) Insider Acquires £149 38 in Stock

Dr. Martens plc (LON:DOCS – Get Free Report) insider Jon Mortimore bought 97 shares of the firm’s stock in a transaction on Friday, August 11th. The shares were purchased at an average price of GBX 154 ($1.95) per share, for a total transaction of £149.38 ($189.50). Jon Mortimore also recently made the following trade(s): On […]

Insider Buying: Dr Martens plc (LON:DOCS) Insider Purchases £399,832 92 in Stock

Dr. Martens plc (LON:DOCS – Get Free Report) insider Kenny Wilson purchased 309,948 shares of the firm’s stock in a transaction on Friday, July 14th. The shares were acquired at an average price of GBX 129 ($1.69) per share, with a total value of £399,832.92 ($522,794.09). Dr. Martens Stock Performance DOCS stock opened at GBX […]

Dr Martens plc (LON:DOCS) Insider Jon Mortimore Acquires 119 Shares

Dr. Martens plc (LON:DOCS – Get Free Report) insider Jon Mortimore bought 119 shares of the firm’s stock in a transaction on Tuesday, July 11th. The shares were bought at an average cost of GBX 126 ($1.62) per share, with a total value of £149.94 ($192.90). Jon Mortimore also recently made the following trade(s): On […]

Dr Martens (LON:DOCS) Earns Overweight Rating from Barclays

Barclays reissued their overweight rating on shares of Dr. Martens (LON:DOCS – Get Rating) in a research report released on Monday morning, MarketBeat Ratings reports. The brokerage currently has a GBX 175 ($2.18) price target on the stock. A number of other analysts have also recently weighed in on DOCS. Numis Securities reiterated an add […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.